Cargando…
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013
Burkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Beca...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285261/ https://www.ncbi.nlm.nih.gov/pubmed/25530077 http://dx.doi.org/10.3201/eid2101.140762 |
_version_ | 1782351557754355712 |
---|---|
author | Wiersinga, W. Joost Birnie, Emma Weehuizen, Tassili A.F. Alabi, Abraham S. Huson, Michaëla A.M. in ’t Veld, Robert A. G. Huis Mabala, Harry K. Adzoda, Gregoire K. Raczynski-Henk, Yannick Esen, Meral Lell, Bertrand Kremsner, Peter G. Visser, Caroline E. Wuthiekanun, Vanaporn Peacock, Sharon J. van der Ende, Arie Limmathurotsakul, Direk Grobusch, Martin P. |
author_facet | Wiersinga, W. Joost Birnie, Emma Weehuizen, Tassili A.F. Alabi, Abraham S. Huson, Michaëla A.M. in ’t Veld, Robert A. G. Huis Mabala, Harry K. Adzoda, Gregoire K. Raczynski-Henk, Yannick Esen, Meral Lell, Bertrand Kremsner, Peter G. Visser, Caroline E. Wuthiekanun, Vanaporn Peacock, Sharon J. van der Ende, Arie Limmathurotsakul, Direk Grobusch, Martin P. |
author_sort | Wiersinga, W. Joost |
collection | PubMed |
description | Burkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Because it has been found in equatorial areas with tropical climates, we hypothesized that B. pseudomallei could exist in Gabon. During 2012–2013, we conducted a seroprevalance study in which we set up microbiology facilities at a large clinical referral center and prospectively screened all febrile patients by conducting blood cultures and testing for B. pseudomallei and related species; we also determined whether B. pseudomallei could be isolated from soil. We discovered a novel B. pseudomallei sequence type that caused lethal septic shock and identified B. pseudomallei and B. thailandensis in the environment. Our data suggest that melioidosis is emerging in Central Africa but is unrecognized because of the lack of diagnostic microbiology facilities. |
format | Online Article Text |
id | pubmed-4285261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-42852612015-01-12 Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 Wiersinga, W. Joost Birnie, Emma Weehuizen, Tassili A.F. Alabi, Abraham S. Huson, Michaëla A.M. in ’t Veld, Robert A. G. Huis Mabala, Harry K. Adzoda, Gregoire K. Raczynski-Henk, Yannick Esen, Meral Lell, Bertrand Kremsner, Peter G. Visser, Caroline E. Wuthiekanun, Vanaporn Peacock, Sharon J. van der Ende, Arie Limmathurotsakul, Direk Grobusch, Martin P. Emerg Infect Dis Research Burkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Because it has been found in equatorial areas with tropical climates, we hypothesized that B. pseudomallei could exist in Gabon. During 2012–2013, we conducted a seroprevalance study in which we set up microbiology facilities at a large clinical referral center and prospectively screened all febrile patients by conducting blood cultures and testing for B. pseudomallei and related species; we also determined whether B. pseudomallei could be isolated from soil. We discovered a novel B. pseudomallei sequence type that caused lethal septic shock and identified B. pseudomallei and B. thailandensis in the environment. Our data suggest that melioidosis is emerging in Central Africa but is unrecognized because of the lack of diagnostic microbiology facilities. Centers for Disease Control and Prevention 2015-01 /pmc/articles/PMC4285261/ /pubmed/25530077 http://dx.doi.org/10.3201/eid2101.140762 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Wiersinga, W. Joost Birnie, Emma Weehuizen, Tassili A.F. Alabi, Abraham S. Huson, Michaëla A.M. in ’t Veld, Robert A. G. Huis Mabala, Harry K. Adzoda, Gregoire K. Raczynski-Henk, Yannick Esen, Meral Lell, Bertrand Kremsner, Peter G. Visser, Caroline E. Wuthiekanun, Vanaporn Peacock, Sharon J. van der Ende, Arie Limmathurotsakul, Direk Grobusch, Martin P. Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title | Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013 |
title_full | Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013 |
title_fullStr | Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013 |
title_full_unstemmed | Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013 |
title_short | Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013 |
title_sort | clinical, environmental, and serologic surveillance studies of
melioidosis in gabon, 2012–2013 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285261/ https://www.ncbi.nlm.nih.gov/pubmed/25530077 http://dx.doi.org/10.3201/eid2101.140762 |
work_keys_str_mv | AT wiersingawjoost clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT birnieemma clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT weehuizentassiliaf clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT alabiabrahams clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT husonmichaelaam clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT intveldrobertaghuis clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT mabalaharryk clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT adzodagregoirek clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT raczynskihenkyannick clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT esenmeral clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT lellbertrand clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT kremsnerpeterg clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT vissercarolinee clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT wuthiekanunvanaporn clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT peacocksharonj clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT vanderendearie clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT limmathurotsakuldirek clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT grobuschmartinp clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 |